Potential Benefit of Scanned Proton Beam versus Photons as Adjuvant Radiation Therapy in Breast Cancer
|
|
- Samantha Ethel Brown
- 6 years ago
- Views:
Transcription
1 Potential Benefit of Scanned Proton Beam versus Photons as Adjuvant Radiation Therapy in Breast Cancer Anna M. Flejmer, MD 1 ; Petra Witt Nyström, MD, PhD 2 ; Frida Dohlmar, MSc 3 ; Dan Josefsson, PhD 3 ; and Alexandru Dasu, PhD 3 1 Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden 2 Department of Oncology, Uppsala University Hospital, Uppsala, Sweden 3 Department of Radiation Physics and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden Submitted 07 July 2014 Accepted 10 Nov 2014 Published 19 Mar 2015 Corresponding author: Anna M. Flejmer Department of Oncology Linköping University Hospital Linköping, Sweden Phone: þ Anna.Maria.Flejmer@ regionostergotland.se Original Article DOI /IJPT * cc Copyright 2015 International Journal of Particle Therapy Distributed under Creative Commons CC-BY Abstract Purpose: To investigate the feasibility of using scanned proton beams as adjuvant radiation therapy for breast cancer. Long-term cardiopulmonary complications may worsen the quality of life and reduce the positive contribution of radiation therapy, which has been known to improve long-term control of locoregional disease as well as the long-term survival for these patients. Materials and Methods: Ten patients with stage I-III cancer (either after mastectomy or lumpectomy, left- or right-sided) were included in the study. The patients were identified from a larger group where dose heterogeneity in the target and/or hotspots in the normal tissues qualified them for irregular surface compensator planning with photons. The patients underwent planning with 2 scanned proton beam planning techniques, single-field uniform dose and intensity-modulated proton therapy, and the results were compared with those from irregular surface compensator. All volumes of interest were delineated and reviewed by experienced radio-oncologists. The patients were prescribed 50 GyRBE in 25 fractions. Dosimetric parameters of interest were compared with a paired, 2-tailed Student t test. Results: The proton plans showed comparable or better target coverage than the original photon plans. There were also large reductions with protons in mean doses to the heart (0.2 versus 1.3 GyRBE), left anterior descending artery (1.4 versus 6.4 GyRBE), and the ipsilateral lung (6.3 versus 7.7 GyRBE). This reduction is important from the point of view of the quality of life of the patients after radiation therapy. No significant differences were found between single-field uniform dose and intensitymodulated proton therapy plans. Conclusion: Spot scanning technique with protons may improve target dose homogeneity and further reduce doses to the organs at risk compared with advanced photon techniques. The results from this study indicate a potential for protons as adjuvant radiation therapy in breast cancer and a further step toward the individualization of treatment based on anatomic and comorbidity characteristics. Keywords: breast radiation therapy; proton radiation therapy; pencil beam scanning; irregular surface compensator; fractionated radiation therapy OPEN ACCESS How to cite this article Flejmer AM, Nyström PW, Dohlmar F, Josefsson D, Dasu A. Potential Benefit of Scanned Proton Beam versus Photons as Adjuvant Radiation Therapy in Breast Cancer. Int J Particle Ther. 2015;1(4):
2 Introduction According to the latest statistics, breast cancer is the most common cancer in women worldwide, both in the more developed and the less developed regions, with the highest incidence rates reported in the developed countries [1, 2]. Radiation therapy is successfully used nowadays to increase long-term control of local and regional disease as well as for long-term survival in patients with breast cancer [3]. Given the high rates of survival after radiation therapy for these patients, great efforts are made to reduce the risk for iatrogenic side effects in the heart and the lung, which may worsen the quality of life or even threaten the life of the patients. Consequently, a broad array of techniques has been developed for breast cancer radiation therapy. The most commonly used technique today is 3-dimensional conformal photon radiation therapy with multileaf collimators, dynamic wedges, and compensating fields, but advanced techniques that use intensity modulation of photon fields have also been explored for their potential to improve the dose homogeneity in the target and to reduce the cardiopulmonary doses [4 6]. More recently, proton radiation therapy has also been proposed as an option in the arsenal of anticancer therapies to further improve the outcome for patients with breast cancer [7, 8]. Indeed, the finite range of the protons and the steep dose falloff at the distal edge of their range could lead to favorable dose distributions [9], which may be of interest from the point of view of the irregular geometry of patients with breast cancer, with their curved surfaces and heterogeneous anatomy. Consequently, several dose planning studies and prospective clinical trials have been initiated to explore the potential of protons for breast radiation therapy [10 20]. These studies reflect the technologic evolution in proton beam technology, with most of the clinical studies using passively scattered proton fields; however, the potential of active scanning beams has been explored in planning studies, as the latter have recently become clinically available. Scanned proton beams have the advantage of allowing further modulation of the beam [9] and reduce the amount of neutrons from in-beam activation in comparison to passively scattered beams [21]. The present study aims to add to the existing knowledge by comparing the potential of protons with the irregular surface compensator technique with photons, for increasing target homogeneity and reducing the doses to organs at risk (OARs) in breast cancer cases not covered by previous studies. Thus, the purpose of this study is to further explore the potential of pencil beam scanning proton technique for breast cancer radiation therapy. Methods and Materials Ten patients with breast cancer (5 left-sided and 5 right-sided) who received postoperative radiation treatment to the whole breast only (WBO) 4 patients or to the breast and the supraclavicular lymph nodes (BSC) 6 patients were included in the analysis. The patients represented difficult cases for which routine conformal radiation therapy with photons led to high heterogeneity in the planning target volume (PTV) or hotspots outside the PTV which were unacceptable according to the criteria used as standards of care thus making them candidates for planning with the irregular surface compensator (ISC) technique [6]. This technique is a forward planning technique implemented in the Eclipse treatment planning system (Varian Medical Systems, Palo Alto, California), using dynamic multileaf collimators to modulate beamlets across the photon fields to improve dose distributions for rounded body contours and target volumes. All patients underwent computed tomography (CT) scanning after surgery, in supine position, with 2-mm slice thickness, for treatment planning. The relevant structures of Flejmer et al. (2015), Int J Particle Ther 846
3 interest, the clinical target volume of the original tumour, the PTV, and the OARs were delineated or approved by experienced radiation oncologists according to local practice. The OARs included the heart, the left anterior descending artery (LAD), the lungs, and the contralateral breast. For 4 patients, bolus was used around the mastectomy scar for photon treatment according to local standards of care. Photon plans were created in the Eclipse treatment planning system, with tangential fields for WBO patients and tangential fields and anteroposterior fields for BSC patients, with a monoisocentric technique with the isocenter placed at the junction between the breast and the supraclavicular region. The tangential fields were planned with the ISC technique by using a transmission penetration depth of 50% [6]. The patients subsequently underwent planning with the Eclipse treatment planning system with scanned proton pencil beams, using both single-field uniform dose (SFUD) and full intensity-modulated proton therapy (IMPT) techniques. In the SFUD technique each proton field attempts to deliver a uniform dose to the PTV, while in the IMPT technique the fields are simultaneously optimized to deliver a uniform dose over the PTV. A 3-field technique has been used in all cases, as it has been suggested that a multifield technique has the flexibility and robustness required for breast cancer radiation therapy with protons [15]. The beam angles used were 208, 608, and 3408 for patients with leftsided breast cancer and 208, 3008, and 3408 for patients with right-sided breast cancer to provide adequate coverage of the PTV and also limit the dose spilling to the contralateral side. A generic value of 1.1 was used for the relative biological effectiveness (RBE) of protons as recommended by the International Commission on Radiation Units and Measurements (ICRU) [22]. All photon and proton plans were normalized so that the mean dose to the PTV was equal to 50 GyRBE in 25 fractions. The resulting plans were dosimetrically evaluated for target coverage and radiation burden to the OARs. For the PTV, the following variables were included in the analysis: the volume receiving at least 93% of the prescribed dose (V 93% ), the ICRU-recommended [23] near minimum dose, D 98% (the dose to 98% of the volume), the near maximum dose, D 2% (the dose to 2% of the volume), and the heterogeneity index (HI), defined as (1) HI ¼ D 2% D 98% ; ð1þ D 50% where D 50% is the median dose to the volume. The comparison for the OARs was performed for dosimetric parameters used either as constraints in international and national recommendations or as parameters for radiobiological models for normal complications [24, 25] and included the mean dose (D mean ) and near maximum dose (D 2% ) (D 2% ) to the OARs. Integral doses in Gykg for photons and in GyRBEkg for protons were also calculated from the average doses and volumes of the structures of interest delineated on the planning CT by using generic values for the volumetric mass densities: 260 kg/m 3 for lungs and 1060 kg/m 3 for all other tissues. A paired, 2-tailed Student t test was used to evaluate the statistical significance of the differences in the dosimetric parameters between the proton and the photon plans. Results The dosimetric parameters for target coverage and normal tissue irradiation for all the patients are summarized in Tables 1 and 2. These results show the potential of both SFUD Flejmer et al. (2015), Int J Particle Ther 847
4 Table 1. Mean values (6 the corresponding standard deviations) for dosimetric parameters for target coverage from the patients included in the study. ISC plans SFUD plans IMPT plans CTV-T D mean Gy GyRBE GyRBE V 95%, % PTV D mean Gy GyRBE GyRBE V 93%, % V 105%, % D 98%, % Gy GyRBE GyRBE D 2%, % Gy GyRBE GyRBE HI, % Abbreviations: ISC, irregular surface compensator; SFUD, single-field uniform dose; IMPT, intensity-modulated proton therapy; CTV-T, clinical target volume of the original tumor; D mean, mean dose; RBE, relative biological effectiveness; V 95%, volume receiving at least 95% of the prescribed dose; PTV, planning target volume; V 93%, volume receiving at least 93% of the prescribed dose; V 105%, volume receiving more than 105% of the prescribed dose; D 98%, dose to 98% of the volume; D 2%, dose to 2% of the volume; HI, heterogeneity index. and IMPT proton plans to reduce the size of the hotspots (V 105% ¼ 4.7% for photons versus 0.4% for SFUD and 0.0% for IMPT) and to improve the dose homogeneity in the target (HI ¼ 12.6% for photons versus 9.0% for SFUD and 5.9% for IMPT). Furthermore, IMPT has potential for improving the coverage of the PTV with the 93% isodose (V 93% ¼ 98.3% with photons and 99.5% with protons, P ¼.01). These results with the proton technique are quite promising for improving target coverage for difficult cases Table 2. Mean values (6 the corresponding standard deviations) for dosimetric parameters for the irradiation of organs at risk from the patients included in the study. ISC plans SFUD plans IMPT plans Heart D mean Gy GyRBE GyRBE D 2% Gy GyRBE GyRBE LAD D mean Gy GyRBE GyRBE D 2% Gy GyRBE GyRBE Lung (ipsilateral) D mean Gy GyRBE GyRBE D 2% Gy GyRBE GyRBE V 20 Gy, % V 10 Gy, % Lung (contralateral) D mean Gy GyRBE GyRBE D 2% Gy GyRBE GyRBE Breast (contralateral) D mean Gy GyRBE GyRBE D 2% Gy GyRBE GyRBE Normal tissue outside PTV Integral dose Gykg GyRBEkg GyRBEkg Abbreviations: ISC, irregular surface compensator; SFUD, single-field uniform dose; IMPT, intensity-modulated proton therapy; D mean, mean dose; RBE, relative biological effectiveness; D 2%, dose to 2% of the volume; LAD, left anterior descending artery; V 20 Gy, volume receiving at least 20 Gy; V 10 Gy, volume receiving at least 10 Gy; PTV, planning target volume. Flejmer et al. (2015), Int J Particle Ther 848
5 Figure 1. Radiation burden to the heart and LAD in the patients with left-sided breast cancer included in the study. Abbreviations: IMPT, intensity-modulated proton therapy; LAD, left anterior descending artery; RBE, relative biological effectiveness; SFUD, single-field uniform dose. beyond what could be achieved with advanced photon techniques such as ISC planning. Indeed, a previous study by the same group [6] has shown that ISC is capable of increasing the homogeneity index in the target, as well as reducing the dose hotspots, in comparison to routine 3-dimensional conformal photon radiation therapy. With respect to the irradiation of the normal tissues, Table 2 shows a trend toward reducing the radiation burden to the heart (D mean ¼ 1.3 Gy for photons versus 0.2 GyRBE for protons and D 2% ¼ 9.8 Gy for photons versus 3.2 GyRBE for protons) and the LAD (D mean ¼ 6.4 Gy for photons versus 1.4 GyRBE for protons, and D 2% ¼ 13.5 Gy for photons versus 4.7 GyRBE for protons). The trend neared statistical significance for patients with left-sided breast cancer (Figure 1, Table 3). For the ipsilateral lung, the Table 3. Mean values (6 the corresponding standard deviations) for dosimetric parameters for the irradiation of the heart and LAD from the patients with left-sided breast cancer included in the study. ISC plans SFUD plans ISC versus SFUD plans IMPT plans ISC versus IMPT plans Heart D mean Gy GyRBE P ¼ GyRBE P ¼.04 D 2% Gy GyRBE P ¼ GyRBE P ¼.20 LAD D mean Gy GyRBE P ¼ GyRBE P ¼.08 D 2% Gy GyRBE P ¼ GyRBE P ¼.07 Abbreviations: ISC, irregular surface compensator; SFUD, single-field uniform dose; IMPT, intensity-modulated proton therapy; D mean, mean dose; RBE, relative biological effectiveness; D 2%, dose to 2% of the volume; LAD, left anterior descending artery. Flejmer et al. (2015), Int J Particle Ther 849
6 Figure 2. Radiation burden to the ipsilateral lung in the patients included in the study. Abbreviations: D, dose; IMPT, intensity-modulated proton therapy; RBE, relative biological effectiveness; SFUD, single-field uniform dose; V, volume. protons generally appear to reduce the radiation burden in terms of mean and near maximum dose, but they might increase the low-dose component of the dose volume histogram (DVH) (Figure 2). However, the trend does not seem to be valid for all patients, as illustrated by the DVH curves in Figure 3. Proton plans also showed a tendency toward increasing the radiation burden of the contralateral breast, probably because of the chosen beam arrangement, but the doses are quite low and would not pose a problem in the case of a previous or a later treatment to the other side (Table 2). Large differences were also found in terms of the integral dose to the normal tissues outside the PTV, with average values of 67 Gykg for photons versus 48 GyRBEkg for both SFUD and IMPT when all patients were included in the analysis. This reduction is mainly caused by the limited range of the protons, as illustrated in Figure 4, and therefore the difference is even higher for the subgroup of BSC patients included in the analysis (79 Gykg for photons versus 53 GyRBEkg for protons). Discussion The results of this study have shown that proton therapy with scanned pencil beams has the potential to improve target coverage and also to reduce the irradiation of the normal tissues in patients with breast cancer beyond what could be achieved with advanced photon techniques. Few similar studies have been found in the recent literature. Thus, Ares et al [15] studied the potential of scanned proton therapy in 20 patients with left-sided breast cancer and more recently, Jimenez et al [18] reported on the use of scanned protons for 5 patients with bilateral breast implants. The present study adds to the existing knowledge by including both WBO and BSC patients to explore a broader range of possible indications. Furthermore, the focus in the present study has been on patients for Flejmer et al. (2015), Int J Particle Ther 850
7 Figure 3. Dose volume histograms for the photon irregular surface compensator plan (dashed curves) and the intensity-modulated proton therapy plan (solid curves) for 1 patient included in the analysis. Abbreviations: LAD, left anterior descending artery; PTV, planning target volume; RBE, relative biological effectiveness. whom routine planning with photons led to high target heterogeneity and/or unacceptable hotspots. This is an important aspect because, for a considerable fraction of patients, 3- dimensional conformal photon radiation therapy routinely used nowadays for breast cancer may lead to good target dose homogeneity and reduced radiation burden to the OARs. Nevertheless, the normal tissue radiation burden should still be decreased for some patients, and therefore the use of more advanced and costly techniques with photons and Figure 4. Axial section showing the dose distributions from the photon irregular surface compensator plan (left panel) and the corresponding proton plan (right panel) for 1 patient included in the analysis. Flejmer et al. (2015), Int J Particle Ther 851
8 protons might have to be explored. With this group of patients in mind, the photon references used for comparison in the present study have been plans created with the ISC technique. Irregular surface compensator is an electronic compensation planning technique that improves dose homogeneity in the target for patients with breast cancer who receive photon radiation therapy, leading to similar dose distributions compared with full volume-based intensity modulated radiation therapy (IMRT) technique [5, 6]. From this perspective, the choice of the ISC technique for the photon plans ensures an advanced clinically used reference against which the real potential of protons to improve dose distributions could be tested. The significant reduction of the mean cardiac doses predicted with protons, from 2.2 Gy with photons to 0.4 GyRBE with P ¼.05withSFUDandP ¼.04 with IMPT, has deep implications for the risk of ischemic heart disease for survivors of radiation therapy. Thus, a recent study [25] showed that the rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray, with no apparent threshold. Consequently, the potential 5-fold reduction identified in this study with protons, in comparison to the ISC technique, makes proton therapy a potential candidate for patients at high risk for coronary events due to unfavourable anatomy or coexisting cardiac morbidities. Similarly, proton therapy has potential for reducing the doses to the LAD, which is a substructure of interest for the development of cardiac complications [26]. The decreasing trend did not reach statistical significance, possibly because of the uncertainties in delineating such a small structure as the LAD on images with standard radiation therapy quality [27]. However, the use of contrast agents for improving the delineation of this structure will further increase the uncertainty of the conversion of CT images into stopping powers for protons needed for dose calculations, and therefore this approach was not used in the present study. The reduction of the dose to the lungs with the use of protons has been identified as a trend only in the present study, while previous studies [15, 18] have reported a significant decrease of the radiation burden for this organ. The difference could result from the present study s use of mainly difficult cases, which required much finer balancing of target coverage and irradiation of the lung to produce clinically acceptable plans. A potentially concerning aspect is the trend toward increasing the low-dose component of the ipsilateral lung DVH with protons, in light of a recent study [28] reporting a strong correlation between radiologic changes in lung morphology and lung volumes receiving low doses. However, patients with radiologic pneumonitis after photon irradiation in the cited study had considerably higher irradiated lung volumes than those reported in the present study, either with photons or with protons; therefore, the clinical impact of the increase is probably quite limited. Nevertheless, further investigations of this aspect are warranted. The present study also found a reduction in the integral body dose with protons versus photons. This was partly expected, since it is generally believed that the finite range of the protons lead to near zero dose behind the target volume [9, 29]. Nevertheless, it is worth mentioning that the largest difference was found for BSC patients, as the photon irradiation technique uses opposing fields through a large volume of normal tissue. For WBO patients the difference in integral doses was much smaller, 48 Gykg for photons versus 40 GyRBEkg for protons, as the photon technique uses tangential fields over the breast to limit the amount of normal tissue irradiated. However, the relative biological effectiveness of the protons is a source of uncertainty in the estimation of integral body dose for protons. Thus, the generic value of 1.1 for the proton RBE has been determined in the mid-position Flejmer et al. (2015), Int J Particle Ther 852
9 of a spread-out Bragg peak [22], while several studies [30 32] have shown that proton RBE varies along the particle track and with the irradiated tissue. Largest variations are expected for late-reacting normal tissues situated in the distal part of the proton s track and beyond, from where most of the contribution to integral dose in proton breast radiation therapy comes. More accurate determinations of integral doses, taking into account the distributions of dose and linear energy transfer in the tissues [33], are beyond the purpose of the present study. It should also be pointed out that the preferred unit for integral body dose from protons should be GyRBEkg, rather than joule, as the joule is a derived unit of energy in the International System of Units (SI). Whereas for photons Gykg is equivalent to joules, the unit used for protons, GyRBEkg, would be equivalent to J (RBE), which does not correspond to the SI definition of joule. Besides the uncertainties in relative biological effectiveness for protons, several other uncertainties may appear for proton dose planning. Thus, CT calibration and range uncertainties are known to influence the calculated proton dose distributions; however, an analysis of this aspect, performed by Ares and colleagues [15] for a similar beam arrangement, found quite a small impact of range uncertainties for breast cancer planning with protons. This is because the beam arrangement used in the present study follows some general principles that provide robustness in proton beam planning, such as the avoidance of a single beam that may go through many anatomic heterogeneities or be directed toward an OAR, and that also allows the sparing of the skin. Furthermore, a small impact was also reported by the same group for respiratory motion, even for the relatively complex spot-scanned IMPT plans. From the perspective of these results, the expected impact of these uncertainties on the resulting dose distributions is rather small. Conclusion The findings of the present study suggest that proton therapy with scanned beams has the potential to improve target coverage and to reduce the radiation burden to OARs in breast radiation therapy beyond what could be achieved with advanced photon techniques. Improving target coverage is particularly important for patients with multifocal or lobular disease for which cold spots in the PTV should be avoided. Similarly, pencil beam scanning techniques with protons could also reduce the doses to OARs, which in turn may translate into reduced iatrogenic toxicity and improved quality of life for the patients after radiation therapy. Depending on anatomic and comorbidity characteristics, this could be a step toward further individualization of treatment for patients with breast cancer. ADDITIONAL INFORMATION AND DECLARATIONS Conflicts of Interest: The authors have no conflicts to disclose. References 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0: cancer incidence and mortality worldwide: IARC CancerBase No Accessed 12/31/ Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in Int J Cancer. 2013;132: Flejmer et al. (2015), Int J Particle Ther 853
10 3. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378: Kestin LL, Sharpe MB, Frazier RC, Vicini FA, Yan D, Matter RC, Martinez AA, Wong JW. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000;48: Chui CS, Hong L, Hunt M, McCormick B. A simplified intensity modulated radiation therapy technique for the breast. Med Phys. 2002;29: Flejmer AM, Josefsson D, Nilsson M, Stenmarker M, Dasu A. Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations. Anticancer Res. 2014;34: Bjork-Eriksson T, Glimelius B. The potential of proton beam radiation therapy in breast cancer. Acta Oncol. 2005;44: Weber DC, Ares C, Lomax AJ, Kurtz JM. Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol. 2006;1: Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, Niemierko A, Hall E, Flanz J, Hallman J, Trofimov A. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 2010;95: Johansson J, Isacsson U, Lindman H, Montelius A, Glimelius B. Node-positive leftsided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol. 2002;65: Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensitymodulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys. 2003;55: Kozak KR, Katz A, Adams J, Crowley EM, Nyamwanda JA, Feng JK, Doppke KP, Delaney TF, Taghian AG. Dosimetric comparison of proton and photon threedimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006;65: Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gadd M, Specht M, Hughes K, Gioioso V, Lu HM, Braaten K, Recht A, Powell SN, DeLaney TF, Taghian AG. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66: Bush DA, Slater JD, Garberoglio C, Yuh G, Hocko JM, Slater JM. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy. Cancer J. 2007;13: Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, Lutters G, Hug EB, Bodis S, Lomax AJ. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys. 2010;76: Bush DA, Slater JD, Garberoglio C, Do S, Lum S, Slater JM. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011;11: MacDonald SM, Jimenez R, Paetzold P, Adams J, Beatty J, DeLaney TF, Kooy H, Taghian AG, Lu HM. Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery. Radiat Oncol. 2013;8:71. Flejmer et al. (2015), Int J Particle Ther 854
11 18. Jimenez RB, Goma C, Nyamwanda J, Kooy HM, Halabi T, Napolitano BN, McBride SM, Taghian AG, Lu HM, MacDonald SM. Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study. Radiother Oncol. 2013;107: MacDonald SM, Patel SA, Hickey S, Specht M, Isakoff SJ, Gadd M, Smith BL, Yeap BY, Adams J, Delaney TF, Kooy H, Lu HM, Taghian AG. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86: Chang JH, Lee NK, Kim JY, Kim YJ, Moon SH, Kim TH, Kim DY, Cho KH, Shin KH. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol. 2013;108: Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65: International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Proton-Beam Therapy. Bethesda, MD: ICRU; ICRU report International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). Bethesda, MD: ICRU; ICRU report Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV, Timmerman RD, Martel MK, Jackson A. Radiation dosevolume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76:S Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368: Nilsson G. Cardiovascular Side Effects of Radiotherapy in Breast Cancer [doctoral thesis]. Uppsala: Uppsala University; Vennarini S, Fournier-Bidoz N, Aristei C, de Almeida CE, Servois V, Campana F, Mosseri V, Fourquet A, Kirova YM. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. Br J Radiol. 2013;86: Blom Goldman U, Wennberg B, Svane G, Bylund H, Lind P. Reduction of radiation pneumonitis by V20-constraints in breast cancer. Radiat Oncol. 2010;5: Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier PA, Coucke PA, Mirimanoff RO. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol. 1999;51: Gerweck LE, Kozin SV. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol. 1999;50: Dasu A, Toma-Dasu I. Impact of variable RBE on proton fractionation. Med Phys. 2013;40: Wedenberg M, Lind BK, Hardemark B. A model for the relative biological effectiveness of protons: the tissue specific parameter alpha/beta of photons is a predictor for the sensitivity to LET changes. Acta Oncol. 2013;52: Wedenberg M, Toma-Dasu I. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans. Med Phys. 2014;41: Flejmer et al. (2015), Int J Particle Ther 855
Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations
Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations Anna M. Flejmer, Dan Josefsson, Mats Nilsson, Margaretha Stenmarker and Alexandru
More informationA Case Study: Proton Therapy for Male Breast Cancer with Previous Irradiation
A Case Study: Proton Therapy for Male Breast Cancer with Previous Irradiation Bosco Q. Giap, BA 1 ; Fantine Giap, BA 2 ; John P. Einck, MD 3 ; Richard LePage, PhD 4 ; Dana M. Blasongame, CMD 4 ; Angela
More informationVariation In Mean Heart Dose By Treatment Plan Optimization During Radiotherapy For Left Sided Breast Cancer
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016 18 Variation In Mean Heart Dose By Treatment Plan Optimization During Radiotherapy For Left Sided Breast Cancer
More informationEpworth Radiation Oncology
Epworth HealthCare Epworth Radiation Oncology Intensity-Modulated Radiotherapy versus Three- Dimensional Conformal Radiotherapy; a retrospective study Emma Fitzgerald Overview Literature search into Breast
More informationThree dimensional conformal radiotherapy for synchronous bilateral breast irradiation using a mono iso-center technique
Polish Journal of Medical Physics and Engineering 2017;23(2):15-19 June 2017 doi: 10.1515/pjmpe-2017-0004 ISSN 1898-0309 Scientific Paper Three dimensional conformal radiotherapy for synchronous bilateral
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationProtocol of Radiotherapy for Breast Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Breast Cancer Indication of radiotherapy Indications for Post-Mastectomy Radiotherapy (1) Axillary lymph node 4 positive (2) Axillary lymph node 1-3 positive:
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationBreast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study
The British Journal of Radiology, 79 (2006), 785 790 SHORT COMMUNICATION Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study
More informationSpecifics of treatment planning for active scanning and IMPT
Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,
More informationDosimetric Comparison of Treatment Techniques: Brachytherapy, Intensity- Modulated Radiation Therapy, and Proton Beam in Partial Breast Irradiation
Dosimetric Comparison of Treatment Techniques: Brachytherapy, Intensity- Modulated Radiation Therapy, and Proton Beam in Partial Breast Irradiation Tara M. Hansen, MD; Gregory K. Bartlett, BS, CMD; Edward
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationAddress for Correspondence: Department of Medical Physics, Khwaja Yunus Ali University, Enayetpur, Sirajgonj ,
ORIGINAL ARTICLE Dosimetric Comparison of Different 3DCRT Techniques in Left Breast Cancer Radiotherapy Planning Abdus Sattar Mollah 1 and Meher Niger Sharmin 2 1 Department of Medical Physics, KhwajaYunus
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationKing s Research Portal
King s Research Portal DOI: 10.1016/j.radonc.2016.11.007 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Wennstig, A-K.,
More informationCardiovascular disease after radiation therapy
Cardiovascular disease after radiation therapy Giovanna Gagliardi Section of Radiotherapy Physics and Engineering Dept. of Medical Physics Karolinska University Hospital, Stockholm EU Scientific Seminar
More informationConsiderations when treating lung cancer with passive scatter or active scanning proton therapy
Mini-Review Considerations when treating lung cancer with passive scatter or active scanning proton therapy Sara St. James, Clemens Grassberger, Hsiao-Ming Lu Department of Radiation Oncology, Massachusetts
More informationThe dependence of optimal fractionation schemes on the spatial dose distribution
The dependence of optimal fractionation schemes on the spatial dose distribution Jan Unkelbach 1, David Craft 1, Ehsan Salari 1, Jagdish Ramakrishnan 1,2, Thomas Bortfeld 1 1 Department of Radiation Oncology,
More informationFeasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment
Chinese Journal of Cancer Original Article Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment Suresh Rana 1 and ChihYao Cheng 2 Abstract The volumetric modulated
More informationProton Therapy for Local-regionally Advanced Breast Cancer Maximizes Cardiac Sparing
Proton Therapy for Local-regionally Advanced Breast Cancer Maximizes Cardiac Sparing Marcio Fagundes, MD 1 ; Eugen B. Hug, MD 2 ; Mark Pankuch, PhD 3 ; Christine Fang, MD 4 ; Shawn McNeeley, MS 5 ; Ling
More informationMargins in SBRT. Mischa Hoogeman
Margins in SBRT Mischa Hoogeman MARGIN CONCEPTS Why do we use margins? Target / tumor To a-priori compensate for (unknown) deviations between the intended target position and the real target position during
More informationDoes the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study
Does the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study Received: 22.04.2008 Accepted: 4.07.2008 Subject: original
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationTreatment Planning (Protons vs. Photons)
Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield
More informationEarly toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer
Journal Articles Donald and Barbara Zucker School of Medicine Academic Works 2015 Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer J. J. Cuaron B.
More informationTomohisa FURUYA*, Satoru SUGIMOTO, Chie KUROKAWA, Shuichi OZAWA, Kumiko KARASAWA and Keisuke SASAI
Journal of Radiation Research, 2013, 54, 157 165 doi: 10.1093/jrr/rrs064 Advance Access Publication 1 August 2012 The dosimetric impact of respiratory breast movement and daily setup error on tangential
More informationA treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse
Peters et al. Radiation Oncology 2014, 9:153 RESEARCH Open Access A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse Samuel Peters
More informationThe Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy
The Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy 1 Donovan EM, 1 Brooks C, 1 Mitchell A, 2 Mukesh M, 2 Coles CE, 3 Evans PM, 1 Harris EJ 1 Joint Department of Physics, The Royal Marsden/Institute
More informationFollow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses Part of the Physical Sciences and Mathematics Commons
Louisiana State University LSU Digital Commons LSU Master's Theses Graduate School 2014 A Treatment Planning Comparison of Volumetric Modulated Arc Therapy and Proton Therapy for a Sample of Breast Cancer
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationLeft Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR)
Global Journal of Breast Cancer Research, 2013, 1, 53-57 53 Left Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR) Giorgia Capezzali
More informationDiscuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons
Mark Pankuch, PhD Discuss the general planning concepts used in proton planning Review the unique handling of CTV / ITV / PTV when treating with protons Pencil Beam distributions and PBS optimization Cover
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationCorrelation between intensity modulated radiotherapy and bone marrow suppression in breast cancer
European Review for Medical and Pharmacological Sciences 2016; 20: 75-81 Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer Q. WANG 1, T. YE 1, H.-L. CHEN
More informationSIMPLE IMPLEMENTATION OF A DIBH TANGENTIAL IMRT TECHNIQUE FOR LEFT-SIDED BREAST CANCER
SIMPLE IMPLEMENTATION OF A DIBH TANGENTIAL IMRT TECHNIQUE FOR LEFT-SIDED BREAST CANCER Dominique Mathieu MD MSc, Nicolas Côté MSc, Andrée-Anne Bernard MD, Noémie Lahaie RTT, Stéphane Bedwani PhD, Jean-François
More informationA new homogeneity index based on statistical analysis of the dose volume histogram
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 2, SPRING 2007 A new homogeneity index based on statistical analysis of the dose volume histogram Myonggeun Yoon, Sung Yong Park, a Dongho
More informationIs there a preferred IMRT technique for left-breast irradiation?
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 3, 2015 Is there a preferred IMRT technique for left-breast irradiation? Marloes Jeulink, a Max Dahele, Philip Meijnen, Ben J. Slotman, Wilko
More informationInfluence of different boost techniques on radiation dose to the left anterior descending coronary artery
Original Article Radiat Oncol J 215;33(3):242-249 http://dx.doi.org/1.3857/roj.215.33.3.242 pissn 2234-19 eissn 2234-3156 Influence of different boost techniques on radiation dose to the left anterior
More informationEvaluation of three APBI techniques under NSABP B-39 guidelines
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 11, NUMBER 1, WINTER 2010 Evaluation of three APBI techniques under NSABP B-39 guidelines Daniel Scanderbeg, a Catheryn Yashar, Greg White, Roger Rice,
More informationTangent field technique of TomoDirect improves dose distribution for whole-breast irradiation
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 3, 2015 Tangent field technique of TomoDirect improves dose distribution for whole-breast irradiation Harumitsu Hashimoto, 1,3a Motoko Omura,
More informationPalliative radiotherapy for thoracic spine metastases: Dosimetric advantage of three dimensional conformal plans
ONCOLOGY LETTERS 10: 497-501, 2015 Palliative radiotherapy for thoracic spine metastases: Dosimetric advantage of three dimensional conformal plans SEUNG GU YEO Department of Radiation Oncology, Soonchunhyang
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationRitu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande
60 Original Article Evaluation of radiograph-based interstitial implant dosimetry on computed tomography images using dose volume indices for head and neck cancer Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*,
More informationVolumetric Modulated Arc Therapy in a Large Body Habitus Patient with Left Breast Cancer: A Dosimetric Study
imedpub Journals http://www.imedpub.com Archives Archives in Cancer in Cancer Research Research ISSN 2254-681 Abstract Volumetric Modulated Arc Therapy in a Large Body Habitus Patient with Left Breast
More informationTo Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence
SCIENCE & TECHNOLOGY To Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence Alburuj R. Rahman*, Jian Z. Wang, Dr. Z. Huang, Dr. J. Montebello Department of
More informationCitation for published version (APA): Laan, H. P. V. D. (2010). Optimising CT guided radiotherapy for breast cancer Groningen: s.n.
University of Groningen Optimising CT guided radiotherapy for breast cancer Laan, Hans Paul van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationRadiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments
Radiation Damage Comparison between Intensity Modulated Radiotherapy () and Field-in-field (FIF) Technique In Breast Cancer Treatments Huisi Ai 1 and Hualin Zhang 2 1. Department of Radiation Oncology,
More informationSarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington
Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation
More informationPost-Lumpectomy Radiation Techniques and Toxicities
Post-Lumpectomy Radiation Techniques and Toxicities Laura Willson, MD Abbott Northwestern Hospital Dept. of Radiation Oncology February 2, 2019 Learning Objectives How radiation therapy works Standard
More informationThe choice of multi beam IMRT for whole breast radiotherapy in early stage right breast cancer
DOI 10.1186/s40064-016-2314-2 RESEARCH Open Access The choice of multi beam IMRT for whole breast radiotherapy in early stage right breast cancer Emel Haciislamoglu 1*, Fatma Colak 1, Emine Canyilmaz 1,
More information8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions
Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation
More informationPost-mastectomy radiotherapy: recommended standards
Post-mastectomy radiotherapy: recommended standards H. Bartelink Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands Introduction The local recurrence rate after mastectomy
More informationThe objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical
The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical sites. The final aim will be to be able to make out these
More informationCitation for published version (APA): Laan, H. P. V. D. (2010). Optimising CT guided radiotherapy for breast cancer Groningen: s.n.
University of Groningen Optimising CT guided radiotherapy for breast cancer Laan, Hans Paul van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More information8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)?
8//06 Clinical Significance of Variations in Proton Therapy H. Paganetti PhD Professor, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Radiation Oncology Introduction
More information3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast
1 Angela Kempen February Case Study February 22, 2012 3D Conformal Radiation Therapy for Mucinous Carcinoma of the Breast History of Present Illness: JE is a 45 year-old Caucasian female who underwent
More informationTreatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 4, FALL 2006 Treatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons Mei Sun and Lijun Ma a University
More informationCorporate Medical Policy
Corporate Medical Policy Intensity Modulated Radiation Therapy (IMRT) of the Chest File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_chest
More informationFuture upcoming technologies and what audit needs to address
Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple
More informationWHOLE-BRAIN RADIOTHERAPY WITH SIMULTANEOUS INTEGRATED BOOST TO MULTIPLE BRAIN METASTASES USING VOLUMETRIC MODULATED ARC THERAPY
doi:10.1016/j.ijrobp.2009.03.029 Int. J. Radiation Oncology Biol. Phys., Vol. 75, No. 1, pp. 253 259, 2009 Copyright Ó 2009 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/09/$ see front
More informationProtons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.
Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry T Gorjiara, Z Kuncic, J Adamovics and C Baldock 2013 J. Phys.: Conf. Ser. 444 012090 PRESAGE is a radiochromic
More informationSilvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida
American Association of Medical Dosimetrists 2015 Silvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida Most
More informationProton and helium beams: the present and the future of light ion beam therapy
Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation
More informationMeasurement of Dose to Critical Structures Surrounding the Prostate from. Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation Therapy (3D-CRT); A Comparative Study Erik
More informationTreatment Planning for Skull Base Tumors PTCOG 52, June 2013
Treatment Planning for Skull Base Tumors PTCOG 52, June 2013 Judy Adams CMD Hanne Kooy Ph.D, Norbert Liebsch MD Department of Radiation Oncology Massachusetts General Hospital Chordomas and Chondrosarcomas
More informationReceived 24 September 2015; accepted 7 November 2015; published 10 November 2015
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 2015, 4, 308-317 Published Online November 2015 in SciRes. http://www.scirp.org/journal/ijmpcero http://dx.doi.org/10.4236/ijmpcero.2015.44037
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationProton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery
MacDonald et al. Radiation Oncology 2013, 8:71 RESEARCH Open Access Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery Shannon M MacDonald *, Rachel
More informationState-of-the-art proton therapy: The physicist s perspective
State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New
More informationSpecification of Tumor Dose. Prescription dose. Purpose
Specification of Tumor Dose George Starkschall, Ph.D. Department of Radiation Physics U.T. M.D. Anderson Cancer Center Prescription dose What do we mean by a dose prescription of 63 Gy? Isocenter dose
More informationA Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population
A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of
More informationA VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 401 410, 2014 A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * M. D. SUDITU 1,2, D. ADAM 1,2, R. POPA 1,2, V. CIOCALTEI
More informationGuang-Hua Jin 1,2, Li-Xin Chen 1*, Xiao-Wu Deng 1, Xiao-Wei Liu 2, Ying Huang 1 and Xiao-Bo Huang 1
Jin et al. Radiation Oncology 2013, 8:89 RESEARCH Open Access A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional
More informationThe dosimetric impact of intra-fraction breath hold variations during mono-isocentric left breast irradiation including nodal regions.
1 The dosimetric impact of intra-fraction breath hold variations during mono-isocentric left breast irradiation including nodal regions. 'A diamond with a flaw is worth more than a pebble without imperfections'
More informationThe Effects of DIBH on Liver Dose during Right-Breast Treatments: A Case Study Abstract: Introduction: Case Description: Conclusion: Introduction
1 The Effects of DIBH on Liver Dose during Right-Breast Treatments: A Case Study Megan E. Sullivan, B.S., R.T.(T)., Patrick A. Melby, B.S. Ashley Hunzeker, M.S., CMD, Nishele Lenards, M.S., CMD, R.T. (R)(T),
More informationComparison of high and low energy treatment plans by evaluating the dose on the surrounding normal structures in conventional radiotherapy
Turkish Journal of Cancer Volume 37, No. 2, 2007 59 Comparison of high and low energy treatment plans by evaluating the dose on the surrounding normal structures in conventional radiotherapy MUHAMMAD BASIM
More informationOriginal Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem
Original Article Treatment Planning Evaluation of Sliding Window and Multiple Static Segments Technique in Intensity Modulated Radiotherapy for Different Beam Directions Teyyiba Kanwal, Muhammad Khalid,
More informationFirst, how does radiation work?
Hello, I am Prajnan Das, Faculty Member in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center. We are going to talk today about some of the basic principles regarding
More informationAdditional Questions for Review 2D & 3D
Additional Questions for Review 2D & 3D 1. For a 4-field box technique, which of the following will deliver the lowest dose to the femoral heads? a. 100 SSD, equal dmax dose to all fields b. 100 SSD, equal
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationAytul OZGEN 1, *, Mutlu HAYRAN 2 and Fatih KAHRAMAN 3 INTRODUCTION
Journal of Radiation Research, 2012, 53, 916 922 doi: 10.1093/jrr/rrs056 Advance Access Publication 21 August 2012 Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung
More informationMartin Stuschke 1,2*, Andreas Kaiser 1,2, Jehad Abu Jawad 1, Christoph Pöttgen 1, Sabine Levegrün 1 and Jonathan Farr 2,3
Stuschke et al. Radiation Oncology 2013, 8:145 SHORT REPORT Open Access Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms
More informationNIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning
NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed
More informationIMPT with Carbon Ions
IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More informationOverview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS
IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS Heng Li, PhD Assistant Professor, Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX, 773
More informationEvaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast
Mendez et al. Radiation Oncology (2018) 13:124 https://doi.org/10.1186/s13014-018-1069-z RESEARCH Open Access Evaluation of a new predictor of heart and left anterior descending artery dose in patients
More informationRadiation qualities in carbon-ion radiotherapy at NIRS/HIMAC
Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationAdvanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*
Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark* Purpose: To evaluate an institution s 3D treatment planning process and the institution
More informationA treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation
Radiotherapy and Oncology 82 (2007) 317 323 www.thegreenjournal.com Breast treatment planning A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationRadiation Planning Index for dose distribution evaluation in stereotactic radiotherapy
Radiation Planning Index for dose distribution evaluation in stereotactic radiotherapy Krzysztof ŚLOSAREK, Aleksandra GRZĄDZIEL, Marta SZLAG, Joanna BYSTRZYCKA Received: 8.4.28 Accepted: 9.8.28 Subject:
More informationMahdi Aghili*, Parisa Seifi, Farshid Farhan, Ahmad Reza Sebzari, Ehsan Mohamadi, Vahid Vaezzadeh a
Original Article Open Access DOI: 10.19187/abc.20163114-18 Assessment of Dose Delivery to Supraclavicular and Axillary Lymph Nodes in Adjuvant Breast Cancer Radiotherapy, with or without Posterior Axillary
More informationTreatment Planning for Lung. Kristi Hendrickson, PhD, DABR University of Washington Dept. of Radiation Oncology
Treatment Planning for Lung Kristi Hendrickson, PhD, DABR University of Washington Dept. of Radiation Oncology Outline of Presentation Dosimetric planning strategies for SBRT lung Delivery techniques Examples
More informationDose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83
Special report Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83 Rapid development in imaging techniques, including functional imaging,
More informationKnowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101. Cases from Duke Clinic. Deon Martina Dick
Knowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101 Cases from Duke Clinic by Deon Martina Dick Department of Medical Physics Duke University Date: Approved: Joseph Lo, Chair
More informationCOMPARISON OF THREE CONCOMITANT BOOST TECHNIQUES FOR EARLY-STAGE BREAST CANCER
doi:10.1016/j.ijrobp.2005.07.004 Int. J. Radiation Oncology Biol. Phys., Vol. 64, No. 1, pp. 168 175, 2006 Copyright 2006 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/06/$ see front
More informationThe Effects of DIBH on Liver Dose during Right-Breast Treatments Introduction
1 The Effects of DIBH on Liver Dose during Right-Breast Treatments Megan E. Sullivan B.S.R.T.(T)., Patrick A. Melby, B.S. Ashley Hunzeker, M.S., CMD, Nishele Lenards, M.S., CMD Medical Dosimetry Program
More informationComparison of IMRT and VMAT Plan for Advanced Stage Non-Small Cell Lung Cancer Treatment
Research Article imedpub Journals www.imedpub.com Archives in Cancer Research DOI: 10.21767/2254-6081.100185 Comparison of IMRT and VMAT Plan for Advanced Stage Non-Small Cell Lung Cancer Treatment Abstract
More information